COVID tests have made pathology companies big profits, but rapid tests are set to shake up the market

  • Written by: Bruce Baer Arnold, Associate Professor, School of Law, University of Canberra
COVID tests have made pathology companies big profits, but rapid tests are set to shake up the marketShutterstock

Throughout the pandemic, Australians with a sniffle or other cold and flu symptoms have been encouraged to get a PCR test – a swab of their throat and the back of their nose, taken by a nurse or doctor. This is then sent to a pathology laboratory for analysis.

So far, a total of 41.5 million COVID PCR tests have been performed in...

Read more: COVID tests have made pathology companies big profits, but rapid tests are set to shake up the marke...